Skip to main content
SpringerLink
Log in

Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Occurrence of aberrant phenotypes in childhood and adult acute leukemia (AL) differs considerably in independent studies and their association with prognostic factors is still controversial. In the present study, 214 patients with AL (106 children and 108 adults) were evaluated for the aberrant expression of CD33 in ALL (B cell and T cell) and CD3, CD5, CD7, and CD19 in AML. In B-ALL, aberrant expression of CD33 was found in 39 and 23% cases of adult and children, respectively. In T-ALL, CD33 was seen in 33% cases of adults while in children CD33 was not observed. In AML, aberrant expression of CD19 was expressed in 52 and 32% while CD7 was expressed in 14 and 15% cases of childhood and adult AML, respectively. Among FAB subtypes, aberrant expression of CD19 and CD7 was more commonly seen in M5 subtype. One adult patient (AML-M5) showed expression of CD3, CD5, and CD19. In summary, aberrant phenotype was commonly seen in adults than childhood B-ALL while in AML, aberrant phenotype was more common in children than adults. CD19 was most commonly expressed antigen followed by CD7 in both childhood and adult AML. Interestingly, aberrant phenotype was not found in childhood T-ALL; however, it was seen in 33% cases of adults. We did not find any association of aberrant phenotype with adverse prognosis factors, CD34 marker, and clinical outcome except the absence of auer rod which was found to be significantly associated with aberrant phenotype of childhood AML (P = 0.01).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Reading CL, Estey EH, Huh YO et al (1993) Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 81(11):3083–3090

    CAS  PubMed  Google Scholar 

  2. Macedo A, Orfao A, Vidriales MB et al (1995) Characterization of aberrant phenotypes in acute myeloblastic leukemia. Ann Hematol 70(4):189–194

    Article  CAS  PubMed  Google Scholar 

  3. Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA (1998) The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification and karyotypic abnormalities. Am J Clin Pathol 109(2):211–220

    CAS  PubMed  Google Scholar 

  4. Bahia DM, Yamamoto M, Chauffaille Mde L et al (2001) Aberrant phenotypes in acute myeloid leukemia: a high frequency and its clinical significance. Haematologica 86(8):801–806

    CAS  PubMed  Google Scholar 

  5. Legrand O, Perrot JY, Baudard M et al (2000) The immunophenotype of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood 96(3):870–877

    CAS  PubMed  Google Scholar 

  6. Cruse JM, Lewis RE, Pierce S, Lam J, Tadros Y (2005) Aberrant expression of CD7, CD56, and CD79a antigens in acute myeloid leukemias. Exp Mol Pathol 79(1):39–41

    Article  CAS  PubMed  Google Scholar 

  7. El-Sissy AH, El-Mashari MA, Bassuni WY, El-Swaayed AF (2006) Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia. J Egypt Natl Cancer Inst 18(3):244–249

    Google Scholar 

  8. Drexler HG, Thiel E, Ludwig WD (1991) Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5(8):637–645

    CAS  PubMed  Google Scholar 

  9. Boldt DH, Kopecky KJ, Head D, Gehly G, Radich JP, Appelbaum FR (1994) Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience. Leukemia 8(12):2118–2126

    CAS  PubMed  Google Scholar 

  10. Preti HA, Huh YO, O’Brien SM et al (1995) Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis. Cancer 76(9):1564–1570

    Article  CAS  PubMed  Google Scholar 

  11. Shen HQ, Tang YM, Yang SL et al (2003) Immunophenotyping of 222 children with acute leukemia by multi-color flow cytometry. Zhonghua Er Ke Za Zhi 41(5):334–337

    PubMed  Google Scholar 

  12. Vitale A, Guarini A, Ariola C et al (2007) Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial. Haematologica 92(3):342–348

    Article  CAS  PubMed  Google Scholar 

  13. Drexler HG, Thiel E, Ludwig WD (1993) Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance. Leukemia 7(4):489–498

    CAS  PubMed  Google Scholar 

  14. Firat H, Favier R, Adam M et al (2001) Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones. Leuk Lymphoma 42(1–2):75–82

    CAS  PubMed  Google Scholar 

  15. Smith LJ, Curtis JE, Messner HA, Senn JS, Furthmayr H, McCulloch EA (1983) Lineage infidelity in acute leukemia. Blood 61(6):1138–1145

    CAS  PubMed  Google Scholar 

  16. Cross AH, Goorha RM, Nuss R et al (1988) Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity. Blood 72(2):579–587

    CAS  PubMed  Google Scholar 

  17. Ball ED, Davis RB, Griffin JD et al (1991) Prognostic value of lymphocyte surface markers in acute myeloid leukemia. Blood 77(10):2242–2250

    CAS  PubMed  Google Scholar 

  18. Smith FO, Lampkin BC, Versteeg C et al (1992) Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significance. Blood 79(9):2415–2422

    CAS  PubMed  Google Scholar 

  19. Kuerbitz SJ, Civin CI, Krischer JP et al (1992) Expression of myeloid-associated and lymphoid-associated cell-surface antigens in acute myeloid leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol 10(9):1419–1429

    CAS  PubMed  Google Scholar 

  20. Sobol RE, Mick R, Royston I et al (1987) Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316(18):1111–1117

    CAS  PubMed  Google Scholar 

  21. Wiersma SR, Ortega J, Sobel E, Weinberg KI (1991) Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N Engl J Med 324(12):800–808

    Article  CAS  PubMed  Google Scholar 

  22. Reiter A, Schrappe M, Ludwig WD et al (1992) Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 80(10):2471–2478

    CAS  PubMed  Google Scholar 

  23. Pui CH, Behm FG, Crist WM (1993) Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82(2):343–362

    CAS  PubMed  Google Scholar 

  24. Uckun FM, Sather HN, Gaynon PS et al (1997) Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children’s Cancer Group. Blood 90(1):28–35

    CAS  PubMed  Google Scholar 

  25. Bhushan B, Ahuja D, Verma S, Saluja S, Siddiqui S, Kapur S (2007) Relation of cell viability and apoptosis with clinical remission following induction chemotherapy in ALL and AML. J Exp Clin Cancer Res 26(3):313–321

    CAS  PubMed  Google Scholar 

  26. Kawai S, Zha Z, Yamamoto Y, Shimizu H, Fujimoto T (1995) Clinical significance of childhood acute myeloid leukemias expressing lymphoid-associated antigens. Pediatr Hematol Oncol 12(5):463–469

    Article  CAS  PubMed  Google Scholar 

  27. Zhu H, Niu T, Meng W, Xu C, Lei S (2002) Immunophenotype of acute leukemia and its clinical significance. Hua Xi Yi Ke Da Xue Xue Bao 33(1):118–120

    CAS  PubMed  Google Scholar 

  28. Lo Coco F, De Rossi G, Pasqualetti D et al (1989) CD7 positive acute myeloid leukaemia: a subtype associated with cell immaturity. Br J Haematol 73(4):480–485

    Article  CAS  PubMed  Google Scholar 

  29. Zutter MM, Martin PJ, Hanke D, Kidd PG (1990) CD7+ acute non-lymphocytic leukemia: evidence for an early multipotential progenitor. Leuk Res 14(1):23–26

    Article  CAS  PubMed  Google Scholar 

  30. Jensen AW, Hokland M, Jorgensen H, Justesen J, Ellegaard J, Hokland P (1991) Solitary expression of CD7 among T-cell antigens in acute myeloid leukemia: identification of a group of patients with similar T-cell receptor beta and delta rearrangements and course of disease suggestive of poor prognosis. Blood 78(5):1292–1300

    CAS  PubMed  Google Scholar 

  31. Kita K, Miwa H, Nakase K et al (1993) Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Blood 81(9):2399–2405

    CAS  PubMed  Google Scholar 

  32. Del Poeta G, Stasi R, Venditti A et al (1994) Prognostic value of cell marker analysis in de novo acute myeloid leukemia. Leukemia 8(3):388–394

    CAS  PubMed  Google Scholar 

  33. Saxena A, Sheridan DP, Card RT, McPeek AM, Mewdell CC, Skinnider LF (1998) Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am J Hematol 58(4):278–284

    Article  CAS  PubMed  Google Scholar 

  34. Lewis RE, Cruse JM, Sanders CM, Webb RN, Suggs JL (2007) Aberrant expression of T-cell markers in acute myeloid leukemia. Exp Mol Pathol 83(3):462–463

    Article  CAS  PubMed  Google Scholar 

  35. Kita K, Nakase K, Miwa H et al (1992) Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80(2):470–477

    CAS  PubMed  Google Scholar 

  36. Thalhammer-Scherrer R, Mitterbauer G, Simonitsch I et al (2002) The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination. Am J Clin Pathol 117(3):380–389

    Article  PubMed  Google Scholar 

  37. Suggs JL, Cruse JM, Lewis RE (2007) Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias. Exp Mol Pathol 83(3):471–473

    Article  CAS  PubMed  Google Scholar 

  38. Ng SM, Ariffin WA, Lin HP, Chan LL, Chin YM (2000) Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children. J Trop Pediatr 46(2):73–78

    Article  CAS  PubMed  Google Scholar 

  39. Pui CH, Raimondi SC, Head DR et al (1991) Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 78(5):1327–1337

    CAS  PubMed  Google Scholar 

  40. Zheng J, Wang X, Hu Y et al (2008) A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China. Cytometry B Clin Cytom 74(1):25–29

    PubMed  Google Scholar 

  41. Yenerel MN, Atamer T, Yavuz AS et al (2002) Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study. Ann Hematol 81(9):498–503

    Article  CAS  PubMed  Google Scholar 

  42. Creutzig U, Harbott J, Sperling C et al (1995) Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood 86(8):3097–3108

    CAS  PubMed  Google Scholar 

  43. Borowitz MJ, Shuster JJ, Civin CI et al (1990) Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: a Pediatric Oncology Group study. J Clin Oncol 8(8):1389–1398

    CAS  PubMed  Google Scholar 

  44. Pui CH, Hancock ML, Head DR et al (1993) Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 82(3):889–894

    CAS  PubMed  Google Scholar 

  45. Cascavilla N, Musto P, D’Arena G, Ladogana S, Matera R, Carotenuto M (1997) Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression. Haematologica 82(1):31–37

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was funded by an extramural grant from the Indian Council of Medical Research (5/13/25/2002-NCD-III).

Conflict of interest statement

The authors declare that they have no conflict of interest related to the publication of this manuscript.

Author information

Authors and Affiliations

  1. Institute of Pathology, Indian Council of Medical Research, Safdarjung Hospital Campus, New Delhi, 110029, India

    Bharat Bhushan, Pradeep Singh Chauhan, Saurabh Verma, Ashwani Kumar Mishra & Sujala Kapur

  2. Department of Hematology, Safdarjung Hospital, New Delhi, 110029, India

    Sumita Saluja

  3. Department of Medical Elementology and Toxicology, Jamia Hamdard, New Delhi, 110062, India

    Saeed Siddiqui

Authors
  1. Bharat Bhushan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pradeep Singh Chauhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sumita Saluja
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Saurabh Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ashwani Kumar Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Saeed Siddiqui
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sujala Kapur
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sujala Kapur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhushan, B., Chauhan, P.S., Saluja, S. et al. Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome. Clin Exp Med 10, 33–40 (2010). https://doi.org/10.1007/s10238-009-0067-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-009-0067-8

Keywords

Search

Navigation